BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23278385)

  • 1. Rapid disease progression in adult-onset mitochondrial membrane protein-associated neurodegeneration.
    Dogu O; Krebs CE; Kaleagasi H; Demirtas Z; Oksuz N; Walker RH; Paisán-Ruiz C
    Clin Genet; 2013 Oct; 84(4):350-5. PubMed ID: 23278385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C19orf12 gene mutations in patients with neurodegeneration with brain iron accumulation.
    Gagliardi M; Annesi G; Lesca G; Broussolle E; Iannello G; Vaiti V; Gambardella A; Quattrone A
    Parkinsonism Relat Disord; 2015 Jul; 21(7):813-6. PubMed ID: 25962551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the C19orf12 and WDR45 genes in patients with neurodegeneration with brain iron accumulation.
    Tschentscher A; Dekomien G; Ross S; Cremer K; Kukuk GM; Epplen JT; Hoffjan S
    J Neurol Sci; 2015 Feb; 349(1-2):105-9. PubMed ID: 25592411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PANK2 and C19orf12 mutations are common causes of neurodegeneration with brain iron accumulation.
    Dezfouli MA; Alavi A; Rohani M; Rezvani M; Nekuie T; Klotzle B; Tonekaboni SH; Shahidi GA; Elahi E
    Mov Disord; 2013 Feb; 28(2):228-32. PubMed ID: 23166001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN.
    Olgiati S; Doğu O; Tufekcioglu Z; Diler Y; Saka E; Gultekin M; Kaleagasi H; Kuipers D; Graafland J; Breedveld GJ; Quadri M; Sürmeli R; Sünter G; Doğan T; Yalçın AD; Bilgiç B; Elibol B; Emre M; Hanagasi HA; Bonifati V
    Parkinsonism Relat Disord; 2017 Jun; 39():64-70. PubMed ID: 28347615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN).
    Gregory A; Lotia M; Jeong SY; Fox R; Zhen D; Sanford L; Hamada J; Jahic A; Beetz C; Freed A; Kurian MA; Cullup T; van der Weijden MCM; Nguyen V; Setthavongsack N; Garcia D; Krajbich V; Pham T; Woltjer R; George BP; Minks KQ; Paciorkowski AR; Hogarth P; Jankovic J; Hayflick SJ
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00736. PubMed ID: 31087512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial membrane protein associated neurodegenration: a novel variant of neurodegeneration with brain iron accumulation.
    Schulte EC; Claussen MC; Jochim A; Haack T; Hartig M; Hempel M; Prokisch H; Haun-Jünger U; Winkelmann J; Hemmer B; Förschler A; Ilg R
    Mov Disord; 2013 Feb; 28(2):224-7. PubMed ID: 23436634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Membrane Protein Associated Neurodegeneration   (MPAN) with a Novel C19orf12 Mutation in the First Decade of Life.
    Gowda VK; Patil A; Srinivasan VM; Kathrani N
    Indian J Pediatr; 2019 Aug; 86(8):746-748. PubMed ID: 30825065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation.
    Hartig MB; Iuso A; Haack T; Kmiec T; Jurkiewicz E; Heim K; Roeber S; Tarabin V; Dusi S; Krajewska-Walasek M; Jozwiak S; Hempel M; Winkelmann J; Elstner M; Oexle K; Klopstock T; Mueller-Felber W; Gasser T; Trenkwalder C; Tiranti V; Kretzschmar H; Schmitz G; Strom TM; Meitinger T; Prokisch H
    Am J Hum Genet; 2011 Oct; 89(4):543-50. PubMed ID: 21981780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial membrane protein-associated neurodegeneration (MPAN).
    Hartig M; Prokisch H; Meitinger T; Klopstock T
    Int Rev Neurobiol; 2013; 110():73-84. PubMed ID: 24209434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological variability in neurodegeneration with brain iron accumulation.
    Vincze A; Kapás I; Molnar MJ; Kovács GG
    Ideggyogy Sz; 2010 Mar; 63(3-4):129-35. PubMed ID: 20405671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain iron and metabolic abnormalities in C19orf12 mutation carriers: A 7.0 tesla MRI study in mitochondrial membrane protein-associated neurodegeneration.
    Dusek P; Mekle R; Skowronska M; Acosta-Cabronero J; Huelnhagen T; Robinson SD; Schubert F; Deschauer M; Els A; Ittermann B; Schottmann G; Madai VI; Paul F; Klopstock T; Kmiec T; Niendorf T; Wuerfel J; Schneider SA
    Mov Disord; 2020 Jan; 35(1):142-150. PubMed ID: 31518459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NBIA Syndromes: A Step Forward from the Previous Knowledge.
    Svetel M; Dragašević N; Petrović I; Novaković I; Tomić A; Kresojević N; Stanković I; Kostić V
    Neurol India; 2021; 69(5):1380-1388. PubMed ID: 34747818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pedigree analysis of C19ORF12 p.Asp18Tyr mutation in a family with mitochondrial membrane protein associated neurodegeneration].
    Li SJ; Wang LL; Qin LZ; Wang XJ; Zhang JW; Li W
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(37):2926-2931. PubMed ID: 31607023
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitochondrial Membrane Protein-Associated Neurodegeneration Mimicking Juvenile Amyotrophic Lateral Sclerosis.
    Kim J; Liao YH; Ionita C; Bale AE; Darras B; Acsadi G
    Pediatr Neurol; 2016 Nov; 64():83-86. PubMed ID: 27671242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegeneration with brain iron accumulation.
    Dusek P; Schneider SA
    Curr Opin Neurol; 2012 Aug; 25(4):499-506. PubMed ID: 22691760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation.
    Hartig MB; Hörtnagel K; Garavaglia B; Zorzi G; Kmiec T; Klopstock T; Rostasy K; Svetel M; Kostic VS; Schuelke M; Botz E; Weindl A; Novakovic I; Nardocci N; Prokisch H; Meitinger T
    Ann Neurol; 2006 Feb; 59(2):248-56. PubMed ID: 16437574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly characterized forms of neurodegeneration with brain iron accumulation.
    Doorn JM; Kruer MC
    Curr Neurol Neurosci Rep; 2013 Dec; 13(12):413. PubMed ID: 24142851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12.
    Landouré G; Zhu PP; Lourenço CM; Johnson JO; Toro C; Bricceno KV; Rinaldi C; Meilleur KG; Sangaré M; Diallo O; Pierson TM; Ishiura H; Tsuji S; Hein N; Fink JK; Stoll M; Nicholson G; Gonzalez MA; Speziani F; Dürr A; Stevanin G; Biesecker LG; ; Accardi J; Landis DM; Gahl WA; Traynor BJ; Marques W; Züchner S; Blackstone C; Fischbeck KH; Burnett BG
    Hum Mutat; 2013 Oct; 34(10):1357-60. PubMed ID: 23857908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution and novel radiological changes of neurodegeneration associated with mutations in C19orf12.
    Skowronska M; Kmiec T; Jurkiewicz E; Malczyk K; Kurkowska-Jastrzębska I; Czlonkowska A
    Parkinsonism Relat Disord; 2017 Jun; 39():71-76. PubMed ID: 28347614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.